- Previous Close
3.350 - Open
3.300 - Bid 3.280 x --
- Ask 3.320 x --
- Day's Range
3.280 - 3.350 - 52 Week Range
3.070 - 5.820 - Volume
172,000 - Avg. Volume
182,608 - Market Cap (intraday)
1.052B - Beta (5Y Monthly) 0.91
- PE Ratio (TTM)
9.94 - EPS (TTM)
0.330 - Earnings Date Mar 31, 2025
- Forward Dividend & Yield 0.06 (1.97%)
- Ex-Dividend Date Jun 10, 2025
- 1y Target Est
5.80
EuroEyes International Eye Clinic Limited provides vision correction services for the treatment of myopia, presbyopia, and cataract in Germany, Denmark, the United Kingdom, and the People's Republic of China. The company offers refractive laser surgery, which include ReLEx SMILE, FemtoLASIK, and Presbyond; phakic lens (ICL) surgery; lens exchange surgery comprising the monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. It also operates consultation centers and clinics for eye treatment and LASIK centers; and sells pharmaceutical products. The company is also involved in the trading of eye clinic equipment and lenses; and ophthalmic equipment renting and spaces operating activities. EuroEyes International Eye Clinic Limited was founded in 1993 and is headquartered in Hamburg, Germany.
www.euroeyes.hk--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 1846.HK
View MorePerformance Overview: 1846.HK
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1846.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1846.HK
View MoreValuation Measures
Market Cap
1.05B
Enterprise Value
712.72M
Trailing P/E
10.10
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.48
Price/Book (mrq)
0.92
Enterprise Value/Revenue
0.97
Enterprise Value/EBITDA
3.62
Financial Highlights
Profitability and Income Statement
Profit Margin
11.50%
Return on Assets (ttm)
3.90%
Return on Equity (ttm)
7.36%
Revenue (ttm)
715.68M
Net Income Avi to Common (ttm)
82.28M
Diluted EPS (ttm)
0.330
Balance Sheet and Cash Flow
Total Cash (mrq)
680.67M
Total Debt/Equity (mrq)
28.36%
Levered Free Cash Flow (ttm)
--